W16* (p.Trp16Ter) variant of ITGA2B (Integrin alpha-IIb)

W16* (p.Trp16Ter) in ITGA2B (Integrin alpha-IIb) is a protein-truncating change. Clinical records from EBI and UniProt describe it as likely pathogenic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.47 / 1. The record also includes structural context.

W16* (p.Trp16Ter) variant details